L’Oréal says GLP-1 use is affecting skincare consumption. Here is how reported facial changes, product testing and personal care decisions differ.
On October 23, 2026, Business Standard reported that the CEO of beauty company L’Oréal said growing GLP-1 use was affecting beauty consumption, particularly skincare. Nicolas Hieronimus made the remarks during an investor call following results for the quarter ended September 30, 2026.
The biological context comes from research and expert reporting rather than the company’s sales commentary:
According to Business Standard, Hieronimus described GLP-1 use as “a very important phenomenon for us.” He said SkinCeuticals had products intended to work alongside these medicines and address concerns such as skin sagging.
L’Oréal’s chief innovation and prospective officer Delphine Viguier-Hovasse said the company was testing products on GLP-1 users in separate studies. Reuters also reported that Galderma and Natura were testing or developing products for consumers concerned about facial sagging and volume loss associated with rapid weight loss.
The business backdrop is substantial. In its official sales release, L’Oréal reported third-quarter 2026 sales of €11.56 billion. Sales rose 7.2% on a like-for-like basis and 7.7% on a reported basis. The release also said skincare continued to accelerate.
Those developments make this a story about companies responding to an appearance concern. Understanding the commercial response and understanding the underlying biology are separate tasks.
Keep the limits together rather than allowing them to blur into a general warning about the medicines:
For a man over 35 using or considering a GLP-1 medicine, the practical response is to separate three questions: the purpose of medical care, the facial change causing concern and the evidence behind a proposed cosmetic purchase. Each deserves an answer on its own terms.
Wanting to look good does not make a health decision less serious. Equally, an appearance concern does not need to become a reason to buy whatever category the beauty industry creates next. The useful adjustment is to bring the concern into the right conversation before turning it into another step in the bathroom.
If facial changes are troubling you, a discussion with the clinician managing your weight-loss care is a more appropriate starting point than a product campaign. The Reuters reporting makes the amount and pace of weight loss relevant topics for that conversation.
Useful questions stay close to what the evidence addresses. What role might the amount or pace of weight loss play in the changes being noticed? How should appearance concerns fit alongside the goals of medical care? Who is qualified to assess the specific concern?
These are discussion prompts rather than instructions to change medication or engineer a particular weight-loss pace. Personal medical decisions belong with qualified care.
For someone thinking about health span, this keeps the discussion wider than a single feature in the mirror. Appearance can remain part of the conversation without becoming the sole measure of whether care is serving its purpose. A company’s interest in a consumer group does not set that person’s priorities.
The language matters. Facial hollowing, skin laxity and more prominent folds are the reported concerns in the review. A broad promise about a healthier-looking face is not the same claim as a measured change in one of those outcomes.
When evaluating a product, identify exactly what the company says it addresses. Then look for the evidence supporting that particular outcome. Questions about what was measured and how the study was conducted are more useful than the presence of “GLP-1” in the marketing.
The phrase “tested on GLP-1 users” describes a study population. Treat it as a reason to examine the study rather than as a verdict about the product. Intended use and demonstrated results belong in different parts of the assessment.
GayFitLab’s coverage of skincare claims during medical weight loss provides a related route into that question. The aim is to connect the purchase to the concern being addressed rather than to the momentum of a new market.
This news does not call for an automatic extra product in a daily routine. A proportionate response is to separate what is already part of your grooming from what a new campaign is asking you to add.
Before making that addition, put its purpose into a plain sentence. Is the purchase being presented as an answer to laxity? Is the concern facial hollowing? Is the appeal simply that the product has been positioned for people taking the same medicine?
That distinction keeps the decision concrete. It also avoids treating every appearance concern associated with weight loss as one interchangeable skincare problem. The category name should not do the work that a specific claim and supporting evidence need to do.
For readers who prefer a focused approach, keeping grooming deliberate rather than crowded is a useful editorial frame. A routine can reflect an interest in appearance without becoming a collection of responses to every new headline.
The practical change is in the decision process: identify the concern, seek appropriate assessment and evaluate the proposed product against its stated purpose. No new regimen follows from the company announcement alone.
For gay men 35+, looking attractive can sit comfortably beside wanting strength, energy and long-term health. There is no need to rank appearance as frivolous or to make looking younger the required outcome.
The popular label attached to these facial changes is less useful than a precise description of what matters to you. A concern about hollowing deserves to be discussed as hollowing. A concern about laxity deserves its own assessment rather than being folded into a broad story about aging badly.
This also leaves room for different preferences. Someone can be comfortable with a visible change. Someone else can want a qualified opinion about it. Neither response needs to follow a prescribed body ideal or a standard model of gay attractiveness.
Keeping those preferences explicit makes it easier to distinguish a personal goal from a goal suggested by marketing. The company news is relevant information, but it is not an instruction about how your face should look.
Bring troubling facial changes to qualified care and judge any new skincare purchase by evidence for the specific concern rather than by its GLP-1 positioning.
At the point of purchase, weighing a weight-loss skincare claim is the reader’s task; GayFitLab translates the underlying research into practical editorial guidance. Its coverage addresses confusing cosmetic messages for gay men 35+ by connecting skin and grooming with healthy aging without medical hype or assumptions about how a man should look.
Stay connected for research-led guidance on fitness, body composition, skin, grooming, vitality, sexual wellbeing, relationships and healthy aging. Clear ideas for gay men 35+ who want to look good, feel strong and age with confidence.
Build habits and systems that support clear thinking, steady energy and long term capacity throughout a demanding career.
explore the Blog
